{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:43:41Z","timestamp":1789404221059,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.soc.2024.12.009","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T03:49:46Z","timestamp":1737344986000},"page":"241-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Metastases"],"prefix":"10.1016","volume":"34","author":[{"given":"Samantha M.","family":"Ruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soc.2024.12.009_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.soc.2024.12.009_bib3","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1245\/s10434-022-12312-7","article-title":"Impact of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer with peritoneal carcinomatosis: a systematic review and meta-analysis","volume":"29","author":"Martins","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.009_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/02656736.2015.1111432","article-title":"Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: from treating the incurable to preventing recurrence","volume":"32","author":"Polom","year":"2016","journal-title":"Int J Hyperthermia"},{"issue":"9742","key":"10.1016\/j.soc.2024.12.009_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.soc.2024.12.009_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","article-title":"Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial","volume":"14","author":"Lordick","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.soc.2024.12.009_bib7","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.3748\/wjg.v20.i14.3905","article-title":"Treatment options in patients with metastatic gastric cancer: current status and future perspectives","volume":"20","author":"Bilici","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.soc.2024.12.009_bib8","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.009_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10120-012-0182-1","article-title":"Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center","volume":"16","author":"Hong","year":"2013","journal-title":"Gastric Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2024.12.009_bib10","article-title":"Review of management and treatment of peritoneal metastases from gastric cancer origin","volume":"12","author":"Manzanedo","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.soc.2024.12.009_bib11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/cancers11111662","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer","volume":"11","author":"Gamboa","year":"2019","journal-title":"Cancers"},{"issue":"30","key":"10.1016\/j.soc.2024.12.009_bib12","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","article-title":"Molecular mechanisms of peritoneal dissemination in gastric cancer","volume":"22","author":"Kanda","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.009_bib13","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1245\/s10434-021-11316-z","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with surgery: a 12-year meta-analysis of this promising treatment strategy for advanced gastric cancer at different stages","volume":"29","author":"Zhang","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.009_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.009_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2024.12.009_bib16","first-page":"1328","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials","volume":"20","author":"Dominic","year":"2021","journal-title":"Excli j"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1\u20132","key":"10.1016\/j.soc.2024.12.009_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000093778","article-title":"Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study","volume":"23","author":"Zhu","year":"2006","journal-title":"Dig Surg"},{"key":"10.1016\/j.soc.2024.12.009_bib19","unstructured":"NCCN, Gastric Cancer. National Comprehensive Cancer Network, 2024. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf2."},{"issue":"2","key":"10.1016\/j.soc.2024.12.009_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SLA.0b013e3181b0c80e","article-title":"Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma","volume":"250","author":"Kuramoto","year":"2009","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.soc.2024.12.009_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10120-013-0306-2","article-title":"Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy","volume":"17","author":"Lee","year":"2014","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.soc.2024.12.009_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","article-title":"Recurrence following curative resection for gastric carcinoma","volume":"87","author":"Yoo","year":"2000","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib23","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1038\/s41598-024-70349-y","article-title":"Novel nomogram and risk stratification for peritoneal recurrence after curative resection in gastric cancer","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"issue":"42","key":"10.1016\/j.soc.2024.12.009_bib24","first-page":"1776","article-title":"Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study","volume":"48","author":"Yonemura","year":"2001","journal-title":"Hepato-Gastroenterology"},{"issue":"10184","key":"10.1016\/j.soc.2024.12.009_bib25","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.soc.2024.12.009_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4251\/wjgo.v12.i7.782","article-title":"Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer","volume":"12","author":"Xie","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.soc.2024.12.009_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.soc.2024.12.009_bib28","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.ejso.2021.05.016","article-title":"Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: a meta-analysis of randomized controlled trials","volume":"47","author":"Granieri","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12957-024-03526-y","volume":"22","author":"Lv","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.soc.2024.12.009_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.soc.2024.12.009_bib31","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1245\/s10434-022-12383-6","article-title":"Don't call it a comeback-HIPEC for gastric cancer","volume":"29","author":"Badgwell","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1186\/s13063-022-06880-y","volume":"23","author":"Di Giorgio","year":"2022","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.soc.2024.12.009_bib33","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1245\/s10434-020-08320-0","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of gastric metastases","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.009_bib34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.soc.2024.12.009_bib35","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2024.12.009_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.suronc.2019.01.005","article-title":"HIPEC and CRS in peritoneal metastatic gastric cancer - who really benefits?","volume":"28","author":"Hotopp","year":"2019","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.soc.2024.12.009_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Portilla","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2024.12.009_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejso.2015.03.231","article-title":"Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis","volume":"41","author":"Coccolini","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.12.009_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.21072","article-title":"Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy","volume":"98","author":"Gonz\u00e1lez-Moreno","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2024.12.009_bib41","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1245\/s10434-020-08234-x","article-title":"The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors","volume":"27","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.009_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4251\/wjgo.v2.i2.85","article-title":"Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer","volume":"2","author":"Yonemura","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib43","doi-asserted-by":"crossref","first-page":"108790","DOI":"10.1016\/j.ejso.2024.108790","article-title":"HIPEC for metastatic gastric cancer: moving the needle towards 3-year survival","volume":"51","author":"Bhutiani","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.009_bib44","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.12.009_bib45","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1245\/s10434-013-3443-2","article-title":"Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan","volume":"21","author":"Canbay","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.009_bib46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C","article-title":"Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery","volume":"79","author":"Fujimoto","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2024.12.009_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.gassur.2003.12.014","article-title":"Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer","volume":"8","author":"Hall","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.12.009_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial","volume":"42","author":"Rau","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.009_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000528609","article-title":"Neoadjuvant chemotherapy followed by cytoreductive surgery and HIPEC improves survival in peritoneal metastatic gastric cancer","volume":"101","author":"Akturk Esen","year":"2023","journal-title":"Oncology"},{"issue":"12","key":"10.1016\/j.soc.2024.12.009_bib50","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1245\/s10434-016-5306-0","article-title":"CRS-HIPEC prolongs survival but is not curative for patients with peritoneal carcinomatosis of gastric cancer","volume":"23","author":"Boerner","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.12.009_bib51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/0284186X.2012.702925","article-title":"Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy","volume":"52","author":"Hultman","year":"2013","journal-title":"Acta Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2024.12.009_bib52","article-title":"Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer","volume":"12","author":"Canbay","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.009_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"11","key":"10.1016\/j.soc.2024.12.009_bib54","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","article-title":"Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma","volume":"24","author":"Badgwell","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.soc.2024.12.009_bib55","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/bjs.11588","article-title":"Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results","volume":"107","author":"van der Kaaij","year":"2020","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.soc.2024.12.009_bib56","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12885-019-5640-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)","volume":"19","author":"Koemans","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.soc.2024.12.009_bib57","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/cam4.2204","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: a retrospective cooperative Central-Eastern European study","volume":"8","author":"Yarema","year":"2019","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.soc.2024.12.009_bib58","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-012-2360-0","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature","volume":"19","author":"Facchiano","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.009_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejso.2007.05.015","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer","volume":"34","author":"Facchiano","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.009_bib60","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur J Surg Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:46:41Z","timestamp":1750862801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1055320724000954"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.12.009","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Metastases","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}